Medical News

RSS

SAIC awarded NIH follow-on task order to provide support to Center for Scientific Review

Science Applications International Corporation (SAIC) announced today its was awarded a follow-on task order by the National Institutes of Health to provide software and technical support to the Center for Scientific Review (CSR). The indefinite-delivery/indefinite-quantity task order has a six month base period of performance, 9 six-month options and a total contract ceiling of more than $24 million if all options are exercised. Work will be performed in Bethesda, Md. The task order was awarded under NIH's Chief Information Officer-Solutions and Partners (CIO-SP2) contract.

3 Jan 2011

Golden Meditech obtains approvals for offering and listing of Taiwan Depositary Receipts

Golden Meditech Holdings Limited, Mainland China's leading integrated healthcare enterprise, is pleased to announce that the Company has obtained the approvals from the Taiwan Stock Exchange and the Taiwan Securities and Futures Bureau for its proposed offering and listing of Taiwan Depositary Receipts ("TDR") on the Taiwan Stock Exchange. The Company will become the first Mainland Chinese healthcare enterprise to list its TDR on the Taiwan Stock Exchange.

3 Jan 2011

MedCath completes sale of TexSan Heart Hospital to Methodist Healthcare System

MedCath Corporation announced today the completion of the sale of substantially all the assets of TexSan Heart Hospital, owned by MedCath and its physician investors, to Methodist Healthcare System of San Antonio. The transaction, which was announced in November, and was subject to customary closing conditions and regulatory requirements, was completed effective December 31, 2010.

3 Jan 2011

MEDNAX acquires Neonatal Medical Associates

MEDNAX, Inc., today announced the acquisition of a neonatal physician group in Long Beach, CA.

3 Jan 2011

Celera seeks FDA premarketing approval for KIF6 Genotyping Assay

Celera Corporation today announced that it has submitted a Premarket Approval Application (PMA) to the U.S. Food and Drug Administration (FDA) for its KIF6 Genotyping Assay, a new molecular In Vitro diagnostic (IVD) test designed to detect a marker for risk of coronary heart disease (CHD) independent of traditional risk factors and aid clinical evaluation when statin treatment is being considered.

3 Jan 2011

Genocea announces close of $35 million Series B venture financing round

Genocea Biosciences Inc., a vaccine discovery and development company pioneering a new class of T cell-based vaccines, today announced that it has closed a $35 million Series B round of venture financing, with new investors Johnson & Johnson Development Corporation (JJDC), Skyline Ventures and MP Healthcare Venture Management, Inc. (MPH) joining existing investors Polaris Venture Partners, Lux Capital Management, SR One, Cycad Group, Auriga Partners and Morningside Ventures.

3 Jan 2011

First Edition: January 3, 2011

Today's headlines include forward looking reports about the health law's possible impact in 2011 as well as early plans for the new Congress.

3 Jan 2011

Innovative approach in revision plastic surgery

Corrective cosmetic surgery cases are definitely on the rise. In fact, revision plastic surgery comprises nearly half of the patients Dr. Sam Rizk, Manhattan Facial Plastic Surgeon treats in his Park Avenue practice. From windblown tight facelifts to ski slope shaped, pointy noses, Dr. Rizk has fixed them all. He believes in a natural looking approach when it comes to doing any facial plastic surgery. Dr. Rizk knows that every nose is as unique as every patient's face is different.

3 Jan 2011

Book on the business side of medicine

The Medical Entrepreneur Pearls, Pitfalls and Practical Business Advice for Doctors (Nano 2.0 Business Press 2010) was written to help physicians, residents and medical students prepare for the business side of private practice. "In medical school curricula there is barely enough time to cover all the necessary medical courses so there certainly is no room for teaching the business of medicine," says Dr. Steven Hacker, author of The Medical Entrepreneur and a successful physician entrepreneur.

3 Jan 2011

Top-line results of TIGER-2 Phase 3 clinical trial for CF treatment

Inspire Pharmaceuticals, Inc. announced today the top-line results from its second Phase 3 clinical trial, TIGER-2, with denufosol tetrasodium for the treatment of cystic fibrosis.

3 Jan 2011

Aceto closes transaction for acquisition of Rising's assets

Aceto Corporation, a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of pharmaceuticals, nutraceuticals, specialty chemicals and crop protection products, today announced that it has closed the previously announced transaction for its wholly-owned subsidiary to acquire certain assets of Rising Pharmaceuticals, Inc ("Rising").

3 Jan 2011

LHC Group announces acquisition of hospice locations in Alabama and Louisiana

LHC Group, Inc., a national provider of home health and hospice, announced today that it has acquired hospice locations in Alabama and Louisiana and entered into a home health joint venture in Kentucky.

3 Jan 2011

Ecron Acunova, Newcastle University sign Memorandum of Understanding for clinical research

Ecron Acunova and Newcastle University have signed a Memorandum of Understanding signalling an intention by both parties to explore ways of working closely together in the area of clinical trials.

3 Jan 2011

People magazine features another Dr. Siegal's Cookie Diet success story

For the second time in three years, Dr. Siegal's Cookie Diet success stories are celebrated in People magazine's annual Half Their Size cover story. Marty and Grace Moorehead of Phoenix lost 182 and 51 pounds respectively by following celebrity weight-loss expert Dr. Sanford Siegal's 36 year old weight-loss regimen under the supervision of their own physicians. Marty Moorehead lost half of his 360 pounds and has kept the weight off for a year. The People article is online at http://tinyurl.com/2vl2apk.

3 Jan 2011

EpiCept regains compliance with continued listing requirement of Nasdaq Capital Market

EpiCept Corporation today announced that it has received notification from the Nasdaq Listing Qualifications Department that it has regained compliance with the continued listing requirement of the Nasdaq Capital Market that it maintain a minimum market value of its listed securities of at least $35 million pursuant to Listing Rule 5550(b)(2).

3 Jan 2011

Hydrocephalus in Ugandan children linked to farm animals, previous bacterial infection

Hydrocephalus in Ugandan children and other developing countries is seasonal, linked to farm animals and in part, caused by previous bacterial infection, according to an international team of researchers from Uganda and the United States, who believe that the best approach to this problem is prevention.

3 Jan 2011

New guideline provides evidence-based recommendation for children undergoing tonsillectomy

A multidisciplinary clinical practice guideline, "Tonsillectomy in Children" will be published in the January issue of Otolaryngology-Head and Neck Surgery.

3 Jan 2011

Tips to prevent a hangover

Dr. Andrew Yacht, director of the division of general medicine and vice chair of medicine for education at Maimonides Medical Center in New York City said, “Alcohol clearly causes hangovers, but why it causes hangovers isn’t very well understood…Part of the suspected cause is dehydration and an electrolyte and hormonal imbalance. Some of the symptoms may be caused by low blood sugar. Or, it may be that the direct toxic effects of alcohol are causing the symptoms.”

2 Jan 2011

Canada’s anti-smoking warnings get larger

Canada will have larger and enhanced warning labels on cigarette packs, it was revealed in a government announcement last Thursday. Health Minister Leona Aglukkaq said that these new warnings will cover three-quarters of the front and back of cigarette packs, up from one-half.

2 Jan 2011

Flu worries continue

As number of cases of flu rise in the UK, Health Secretary Andrew Lansley is under pressure to strengthen the flu vaccination campaign. He reinstated a public health “Catch It, Bin It, Kill It” advertising campaign after he was warned by government advisers of the need to improve immunization rates which are at their lowest this winter for many years. It had been discontinued despite helping educate the public to adopt good hygiene habits during last year’s H1N1 swine flu epidemic at a cost of just £609,000. There were 12 more deaths in the last week from flu, bringing the total this winter to 39, the Health Protection Agency (HPA) said today. Thirty-six were killed by H1N1 swine flu, which is the most virulent of the two main flu strains currently circulating. The others died after contracting Influenza B, the other strain. All except one of the 39 were under 65 and four were under five.

2 Jan 2011